MGO One Seven’s Cardiol Therapeutics CRDL Stock Holding History

MGO One Seven’s Portfolio CRDL Stock Details CRDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$135K	Hold	100,000	–	–	﹤0.01%	1367
2025 Q4	$95.4K	Hold	100,000	–	–	﹤0.01%	1369
2025 Q3	$107K	Hold	100,000	–	–	﹤0.01%	1293
2025 Q2	$136K	Hold	100,000	–	–	﹤0.01%	1162
2025 Q1	$97K	Hold	100,000	–	–	﹤0.01%	1065
2024 Q4	$128K	Hold	100,000	–	–	﹤0.01%	1035
2024 Q3	$198K	Hold	100,000	–	–	0.01%	941
2024 Q2	$202K	Hold	100,000	–	–	0.01%	909
2024 Q1	$181K	Hold	100,000	–	–	0.01%	853
2023 Q4	$84.3K	Hold	100,000	–	–	﹤0.01%	877
2023 Q3	$89.5K	Hold	100,000	–	–	0.01%	804
2023 Q2	$89K	Buy	+100,000	New	+$66K	0.01%	764
2022 Q4	–	Sell	-10,000	Closed	-$10	–	748
2022 Q3	$10	Hold	10,000	–	–	﹤0.01%	712
2022 Q2	$13K	Buy	+10,000	New	+$14.2K	﹤0.01%	639

Other funds holding CRDL

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return

Ikarian Capital Dallas, Texas $699M AUM 600.17% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return

Boothbay Fund Management New York $4.34B AUM 106.31% 1-Year Est. Return

Two Sigma Investments

Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return

Integrity Alliance Urbandale, Iowa $2.63B AUM 16.75% 1-Year Est. Return

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return